Luminary is a clinical stage CAR-T therapy company with a novel allogeneic manufacturing platform where our CAR and or TCR development utilizes gamma delta cells. What makes our allogeneic therapeutics unique are that our final drug product includes the combinatory power of both the Vẟ1 and Vẟ2 gamma delta cells giving our therapies the power of both innate and adaptive cancer clearing power. We have multiple solid tumor targets under development with a proprietary signaling method to ensure T-Cell persistence. Additionally, our Ligand BAFF CAR for hematologic cancers is designed with 3 antigen receptors specifically designed to overcome antigen escape.
For more information visit www.luminarytx.com
Company Details
- Employees
- 16
- Founded
- -
- Address
- 1621 E Hennepin Ave,
- Phone
- 612-309-7653
- j.****@****ytx.com
- Industry
- Biotechnology
- Website
- luminarytx.com
- HQ
- Minneapolis, MN
Luminary Therapeutics, Inc Questions
Luminary Therapeutics, Inc's helpline number is 612-309-7653
Luminary Therapeutics, Inc's website is luminarytx.com
Luminary Therapeutics, Inc's LinkedIn profile is https://www.linkedin.com/company/luminary-therapeutics-inc
Luminary Therapeutics, Inc has
16 employees.
View email and phone details for 16
employees at Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc's industry is
Biotechnology
Luminary Therapeutics, Inc's top competitors are
Cartesian Therapeutics,
Reprise Biomedical,
B-Mogen Biotechnologies, Inc.,
Celcuity,
Diamedica Therapeutics Inc.,
Icell Gene Therapeutics,
A2 Biotherapeutics, Inc.,
Immpact Bio,
Catamaran Bio,
Kyverna Therapeutics.
Luminary Therapeutics, Inc's support email address is j.liter@luminarytx.com
Luminary Therapeutics, Inc's categories are Biotechnology
Luminary Therapeutics, Inc's founding year is 2019
